|
2016
|
Invention
|
Method of treating chronic obstructive pulmonary disease (cpd) with verproside. subintegrum conta... |
|
|
Invention
|
Subintegrum containing abundant amount of active ingredient. subintegrum than that prepared by th... |
|
|
Invention
|
Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the ... |
|
|
Invention
|
A compound (ks 513) isolated from pseudolysimachion rotundum var. subintegrum, the composition co... |
|
|
Invention
|
A novel compound (ks 513) isolated from pseudolysimachion rotundum var. subintegrum, the composit... |
|
2015
|
Invention
|
Compound isolated from pseudolysimachion rotundum var. subintegrum. The present invention relates... |
|
|
Invention
|
A novel compound isolated from pseudolysimachion rotundum var. subintegrum containing abundant am... |
|
2014
|
Invention
|
Stauntonia hexaphylla leaf extract as active ingredient. stauntonia hexaphylla leaf extract accor... |
|
|
Invention
|
Pharmaceutical composition for promoting bone tissue formation, containing stauntonia hexaphylla ... |
|
|
Invention
|
Subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, ... |
|
|
Invention
|
The composition comprising atc2 purified extract isolated from pseudolysimachion rotundum var. su... |
|
|
Invention
|
The composition comprising verproside isolated from pseudolysimachion rotundum var. subintegrum f... |
|
|
Invention
|
The composition comprising a purified extract isolated from pseudolysimachion rotundum var. subin... |
|
2013
|
Invention
|
Subintegrum containing abundant amount of active ingredient, the preparation thereof, and the com... |
|
|
Invention
|
Purified extract isolated from pseudolysimachion rotundum var. subintegrum, and the composition c... |
|
|
Invention
|
Atc2 purified extract isolated from pseudolysimachion rotundum var. subintegrum, and the composit... |
|
|
Invention
|
A purified extract isolated from pseudolysimachion rotundum var. subintegrum containing abundant ... |
|
2012
|
Invention
|
Medical composition comprising stauntonia hexaphylla extract. Disclosed is an antipyretic ... |
|
|
Invention
|
Medical composition comprising stauntonia hexaphylla extract. Disclosed is an antipyretic d... |
|
|
Invention
|
Medical composition containing stauntonia hexaphylla extract. The present invention relates to a ... |
|
2008
|
Invention
|
Thiazolidine derivatives and methods for the preparation thereof.
The present invention relates ... |
|
|
Invention
|
Quinoline derivatives as caspase-3 inhibitor, preparation process for the same and pharmaceutical... |
|
2007
|
Invention
|
Water soluble composition containing coenzyme q10. A water soluble composition containing coenzym... |
|
2004
|
Invention
|
Novel cephalosporin derivatives, its pharmaceutically acceptable salts and manufacturing process ... |
|
|
Invention
|
Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutic... |
|
1997
|
Invention
|
Heterocycle-fused thiazole derivatives. A thiazole compound represented by general formula (I), w... |
|
|
Invention
|
4-amino-3-acylnaphthyridine derivatives. Novel 4-amino-3-acylnaphthyridine derivatives represent... |
|
1996
|
Invention
|
Pharmaceutical composition for skin diseases. The present invention relates to novel pharmaceutic... |
|
|
Invention
|
Heterocycle-fused thiazole derivatives. A thiazole compound represented by the followingge... |
|
|
Invention
|
Thiazolyl triazolothiazole derivatives. Novel thiazolyl triazolothiazole derivatives represented ... |
|
|
Invention
|
Benz- or pyrido-imidazole derivatives. A benz- or pyrido-imidazole compounds represented by gener... |
|
|
Invention
|
4-amino-3-acylnaphthyridine derivatives. A novel 4-amino-3-acylnaphthyridine derivatives re... |
|
|
Invention
|
4-amino-3-acylnaphthyridine derivatives. A novel 4-amino-3-acylnaphthyridine derivatives represen... |
|
1995
|
Invention
|
Novel pharmaceutical composition for skin diseases. The present invention relates to novel pharma... |
